Table 1: Demographical and clinical characteristics of patients with Graves’ disease and Hashimoto’s thyroiditis.

Graves’ disease ( = 198)Hashimoto's thyroiditis ( = 77)

Gender—male/female (%)18/180 (9.09/90.91)5/72 (6.49/93.51)
Age—yrs (range)45.5 (13–84)51 (15–84)
Age at diagnosis—yrs (range)36.5 (9–81)48 (5–77)
Disease duration—yrs (range)9.08 (0.5–27)3 (0.1–21)
Total thyroid volume—cc (range)55.7 (1.6–242)15.8 (1–111.9)
Nodules present (%)55 (27.78)39 (50.65)
PTC (%)10 (5.05)6 (7.79)
Time of followup—yrs (range)5 (0.1–20)7 (0.1–21)
Smoking (%)a67 (50.38)14 (41.18)
Time of treatment—yrs (range)5.5 (0.1–20)6.6 (1–16)
Ophthalmopathy (%)b27 (19.71)NA
Active disease (%)176 (88.89)NA
Radioiodine treatment (%)66 (33.33)NA

a = 133 for GD and = 34 for HT.
b = 137.
NA: not available.